Oncogenic Role of Skp2 and p27Kip1 in Intraductal Proliferative Lesions of the Breast△
中国医学科学杂志(英文版)2012年27卷第3期 页码:161-166
• Original Article •|Updated:2024-04-10
|
Share with wechat friends or circle of friends
Export references
Oncogenic Role of Skp2 and p27Kip1 in Intraductal Proliferative Lesions of the Breast△
Affiliations:
1. 1Department of Acupuncture and Moxibustion, Tianjin University of Traditional Chinese Medicine,Tianjin,China,300193
2. 2Breast Cancer Research and Pathology Laboratory, Cancer Institute & Hospital of Tianjin Medical University,Tianjin,China,300060
Author bio:
Funds:
DOI:
中图分类号:
网络出版日期:2012-10-08,
纸质出版日期:2012
Accepted:
Scan QR Code
Yan Lv?, Yun Niu, Xiu-min Ding, 等. Oncogenic Role of Skp2 and p27Kip1 in Intraductal Proliferative Lesions of the Breast△[J]. 中国医学科学杂志(英文版), 2012,27(3):161-166.
Yan Lv?, Yun Niu, Xiu-min Ding, et al. Oncogenic Role of Skp2 and p27Kip1 in Intraductal Proliferative Lesions of the Breast△[J]. Chinese medical sciences journal, 2012, 27(3): 161-166.
Yan Lv?, Yun Niu, Xiu-min Ding, 等. Oncogenic Role of Skp2 and p27Kip1 in Intraductal Proliferative Lesions of the Breast△[J]. 中国医学科学杂志(英文版), 2012,27(3):161-166.DOI:
Yan Lv?, Yun Niu, Xiu-min Ding, et al. Oncogenic Role of Skp2 and p27Kip1 in Intraductal Proliferative Lesions of the Breast△[J]. Chinese medical sciences journal, 2012, 27(3): 161-166.DOI:
Oncogenic Role of Skp2 and p27Kip1 in Intraductal Proliferative Lesions of the Breast△
to S-phase kinase-associated protein 2 (Skp2) plays an oncogenic role in intraductal proliferative lesions of the breast. Methods Here we investigated the mechanism involved in association of Skp2’s degradation of p27
Kip1
with the breast carcinogenesis by immunohistochemical method through detection of Skp2 and p27
Kip1
protein levels in 120 paraffin-embedded tissues of intraductal proliferative lesions including usual ductal hyperplasia (UDH
n=30)
atypical ductal hyperplasia (n=30)
flat epithelial atypia (FEA
n=30)
and ductal carcinoma in situ (DCIS
n=30).Moreover
the expression status of Skp2 and p27
Kip1
in 30 cases of the normal breast paraffin-embedded tissues were explored. Results The DCIS group was with the highest Skp2 level and the lowest p27
Kip1
level
and the UDH group was with the lowest Skp2 level and the highest p27
Kip1
level.Both Skp2 and p27
Kip1
levels in the DCIS group were significantly different from those in the UDH group (all P
<
0.01).The levels of Skp2 and p27
Kip1
in the FEA group were significantly different from both the DCIS and UDH groups (all P
<
0.05).p27
Kip1
was negatively correlated with Skp2 in both the UDH group (r=-0.629
P=0.026) and DCIS group (r=-0.893
P=0.000). Conclusion Overexpression of Skp2 might be the mechanism underlying p27
Kip1
over degradation.
Abstract
To investigate whether the connection of p27
Kip1
to S-phase kinase-associated protein 2 (Skp2) plays an oncogenic role in intraductal proliferative lesions of the breast. Methods Here we investigated the mechanism involved in association of Skp2’s degradation of p27
Kip1
with the breast carcinogenesis by immunohistochemical method through detection of Skp2 and p27
Kip1
protein levels in 120 paraffin-embedded tissues of intraductal proliferative lesions including usual ductal hyperplasia (UDH
n=30)
atypical ductal hyperplasia (n=30)
flat epithelial atypia (FEA
n=30)
and ductal carcinoma in situ (DCIS
n=30).Moreover
the expression status of Skp2 and p27
Kip1
in 30 cases of the normal breast paraffin-embedded tissues were explored. Results The DCIS group was with the highest Skp2 level and the lowest p27
Kip1
level
and the UDH group was with the lowest Skp2 level and the highest p27
Kip1
level.Both Skp2 and p27
Kip1
levels in the DCIS group were significantly different from those in the UDH group (all P
<
0.01).The levels of Skp2 and p27
Kip1
in the FEA group were significantly different from both the DCIS and UDH groups (all P
<
0.05).p27
Kip1
was negatively correlated with Skp2 in both the UDH group (r=-0.629
P=0.026) and DCIS group (r=-0.893
P=0.000). Conclusion Overexpression of Skp2 might be the mechanism underlying p27
ESTROGEN RECEPTOR-NEGATIVE BREAST CANCER CELLS TRANSFECTED WITH ESTROGEN RECEPTOR EXHIBIT DECREASED TUMOUR PROGRESSION AND SENSITIVITY TO GROWTH INHIBITION BY ESTROGEN
THE CORRELATIONS OF CLINICOPATHOLOGIC FEATURES, HORMONE RECEPTOR LEVEL WITH THE PROGNOSIS OF BREAST CANCER: REPORT OF 308 CASES IN ELDERLY WOMEN
CORRELATION BETWEEN SERUM HER-2 ONCOPROTEIN AND PATIENTS WITH BREAST CANCER
PREDICTION OF NON-SENTINEL LYMPH NODE METASTASES IN BREAST CANCER
KNOCKDOWN OF SURVIVIN EXPRESSION BY SMALL INTERFERING RNA SUPPRESSES PROLIFERATION OF TWO HUMAN CANCER CELL LINES